Interpreting the Report

The Report:

A detailed Breast Recurrence Score^® report is generated for each patient containing a Recurrence Score® result

The Score:

A quantitative score, based on a continuous scale of 0-100. The score reflects individual tumor biology—the higher the score, the higher the risk of distant recurrence and the higher the likelihood of chemotherapy benefit for that patient

The Endpoints:

Assesses the 9-year risk of distant recurrence in node-negative patients¹

5-year distant recurrence or mortality in node-positive patients²

Likelihood that chemotherapy will benefit your patient^3,4

The relevance of the ER score by RT-PCR

How your patient's score is generated

The Breast Recurrence Score test is a genomic test that measures the expression of cancer-related genes in your patient’s tumor. Your patient’s score is based on the expression of 21 specific genes from tumor tissue removed during the surgery or core biopsy. Looking at the expression of this unique set of genes, the score provides important information about how likely your patient’s cancer is to return and the likelihood of benefit, or not, from chemotherapy.

Breakdown of the 21 genes included in the assay:

Getting the results

Most Breast Recurrence Score reports are available within 2 weeks from the date the specimen is received in the Exact Sciences lab. You can access the results through the online physician portal or receive the report by fax.

Go to physician portal